Math problem with results, page-260

We will see, if indeed (as expected) they provide a thorough pre-clinical trials with even worst data collections than expected and known to us it will shock the market and pps will get back to 15-20c (we should expect an announcement in 2 weeks time), then on solid pediatric and adult clinical trials in the next 4-6 month from the parallel clinical trials with excellent CI 95% numbers in the announcement, it will get back to 30c......pending FDA approval.
Solid revenue means they have gotten FDA approval for both pediatric and adult, the patented IP alone will be worth $300M in this case.......so at least 40c so 60c on revenue???????

These are all IMO, like yours so DYOR.